WO2005051280A2 - Method and apparatus for controlling a ventilator - Google Patents
Method and apparatus for controlling a ventilator Download PDFInfo
- Publication number
- WO2005051280A2 WO2005051280A2 PCT/US2004/035393 US2004035393W WO2005051280A2 WO 2005051280 A2 WO2005051280 A2 WO 2005051280A2 US 2004035393 W US2004035393 W US 2004035393W WO 2005051280 A2 WO2005051280 A2 WO 2005051280A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- peep
- value
- ratio
- oxygen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 97
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 95
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 95
- 239000001301 oxygen Substances 0.000 claims abstract description 95
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 64
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 38
- 230000000241 respiratory effect Effects 0.000 claims abstract description 34
- 230000035565 breathing frequency Effects 0.000 claims abstract description 32
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 26
- 238000009423 ventilation Methods 0.000 claims description 50
- 230000000694 effects Effects 0.000 claims description 15
- 239000007789 gas Substances 0.000 claims description 15
- 230000003434 inspiratory effect Effects 0.000 claims description 13
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 12
- 239000013256 coordination polymer Substances 0.000 claims description 11
- 102000001554 Hemoglobins Human genes 0.000 claims description 10
- 108010054147 Hemoglobins Proteins 0.000 claims description 10
- 238000012937 correction Methods 0.000 claims description 8
- 230000000284 resting effect Effects 0.000 claims description 7
- 230000037323 metabolic rate Effects 0.000 claims description 6
- 208000000782 Intrinsic Positive-Pressure Respiration Diseases 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 206010021143 Hypoxia Diseases 0.000 claims description 3
- 208000010378 Pulmonary Embolism Diseases 0.000 claims description 3
- 230000006870 function Effects 0.000 claims description 3
- 208000018875 hypoxemia Diseases 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 238000002106 pulse oximetry Methods 0.000 claims 5
- 230000003247 decreasing effect Effects 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 3
- 230000000630 rising effect Effects 0.000 claims 2
- 238000009795 derivation Methods 0.000 claims 1
- 244000144985 peep Species 0.000 abstract 1
- 238000006213 oxygenation reaction Methods 0.000 description 10
- 230000003519 ventilatory effect Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 238000005399 mechanical ventilation Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
- A61M16/026—Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0051—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes with alarm devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0057—Pumps therefor
- A61M16/0063—Compressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/435—Composition of exhalation partial O2 pressure (P-O2)
Definitions
- the present invention relates to a method and apparatus for controlling a ventilator such as a mechanical ventilator (i.e. an artificial respirator) or a respiratory assist device.
- a ventilator such as a mechanical ventilator (i.e. an artificial respirator) or a respiratory assist device.
- the present invention relates to a method and apparatus for controlling a ventilator based on the measured levels of oxygen of the patient on the ventilator, as well as other physical conditions of the patient.
- the present invention describes a method and apparatus that can reliably and robustly control PEEP (or CPAP), and F t o 2 .
- PEEP or CPAP
- F t o 2 novel features which significantly improve the oxygenation of patients during ventilatory therapy provided by mechanical ventilators as well as respiratory devices such as CPAP machines.
- the I:E ratio of the patient can be automatically adjusted and by further inclusion of the features of US Patent No. 4,986,268, the breathing frequency, and tidal volume can be automatically controlled in mechanical ventilation.
- Application of these features results in a significantly more effective and optimal treatment to the patient based on his/her conditions and requirements, in total or assist ventilatory therapy.
- a method and apparatus for controlling a ventilator includes first means receiving at least input data indicative of the patient's measured oxygen levels, and in a more elaborate embodiment of the invention, the first means also receives respiratory mechanics and/or pressure- volume data, as well as data indicative of measured carbon dioxide levels of the patient.
- the first means which preferably comprises a programmable microprocessor, is controlled by a software algorithm to operate on the input data, and to provide digital output data to control the ventilator and the gas mixer of the ventilator.
- the software algorithm is divided into two control programs.
- One control program which can either be used by itself or along with the other program, is designed to automatically adjust F ⁇ ) 2 and PEEP (or CPAP), based on at least the measured oxygen levels of the patient.
- the control program also operates on data from a pressure volume (PV) monitor/analyzer to set the initial PEEP value in certain groups of respiratory patients.
- the processing means detects hazardous conditions based on the input data and/or artifacts, replaces and/or corrects the measurement artifacts, and instructs generation of appropriate warning signals.
- the other control program most of which is described in US Patent No.
- 4,986,268 is designed to control the frequency and ventilation for a next breath of the patient on the ventilator based on at least data indicative of measured CO 2 and O 2 levels of the patient, barometric pressure (as a reference pressure), and respiratory elastance and airway resistance (respiratory mechanics) data; and to make necessary adjustments in the I:E ratio based on the patient's respiratory mechanics data.
- the output data from the 1 st means indicative of PEEP (or CPAP), F 102 , the adjustment in the I:E ratio, breathing frequency, and ventilation, and status of alarms are transmitted to a Signal Generator which is equipped with converters and/or other electronic components to generate the control and appropriate warning signals.
- the control signals for the breathing frequency, ventilation, PEEP (or CPAP), and the adjustment in the I:E ratio are supplied to the ventilator.
- the control signal for F ⁇ )2 is supplied to a mixer regulator unit which adjusts the concentration of oxygen added to the inhalation gas in the gas mixer of the ventilator. Based on the instructions from the 1 st means, the alarm circuit generates appropriate warning signals when needed.
- FIGS 1-4 illustrate a preferred embodiment of the present invention. However, it is understood that this invention is not limited to the precise arrangements shown in the figures and can be embodied in other arrangements without deviating from the scope of the invention.
- Figure 1 is a block diagram of a mechanical ventilator and the control apparatus according to an alternative embodiment of the invention.
- Figures 2a-2c show the flow chart of a software algorithm that also incorporates the control technique described in US Patent No. 4,986,268, to automatically control breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient on the ventilator, according to a preferred method of the present invention.
- Figures 3a-3i show the flow chart of a software algorithm to automatically control PEEP (or CPAP) and F ⁇ o 2 according to a preferred method of the present invention.
- Figures 4a-c show a preferred detailed schematic diagram of a Signal Generator and an Alarm Circuit, for use in a preferred practice of the present invention.
- ventilator refers to a device which is used to provide total or assist ventilatory treatment to patients, and includes mechanical ventilators (i.e. artificial respirators) or CPAP (Continuous Positive Airway Pressure) machines.
- mechanical ventilators i.e. artificial respirators
- CPAP Continuous Positive Airway Pressure
- PEEP represents “Positive End-Expiratory Pressure” and is interchangeable with the term “CPAP,” which represents “Continuous Positive Airway Pressure,” for example, when assist ventilation is provided to spontaneously breathing subjects.
- F 102 represents "concentration of oxygen in a patient's inspiratory gas" which is the same as “fraction of inspired oxygen.”
- I:E represents the "ratio of inspiration time to expiration time.”
- FIG. 1 shows a block diagram according to an alternative practice of the present invention.
- the digital processor 10 includes a programmable controller coupled to receive the outputs of 8 bit A/D converters 12, 14 and 16 as shown.
- the A/D converters 18 and 20 are each a single 8 bit A/D converter.
- the A/D converter unit 22 is an A/D board containing three 8 bit A/D converters.
- the inputs 24, 26, and 28 of the A/Ds are from an oxygen sensor, preferably a pulse oximeter, 30, a CO 2 sensor, such as a transcutaneous monitor or preferably a capnograph, 32, and a lung mechanics calculator and PV monitor, 34.
- the outputs 24, and 26 are each a single analog signal while the output 28 represents 3 analog signals; 1- representing respiratory elastance, 2- representing respiratory airway resistance (air viscosity factor in the lungs), and 3- representing the lower inflection point on the inspiratory or expiratory PV curve of the patient, or alternatively, the measured intrinsic PEEP (PEEPi) of the patient on the ventilator.
- the inputs to the oxygen sensor and the carbon dioxide sensor are respectively shown at 40 and 42 coming from the patient.
- the input 40 is preferably the arterial hemoglobin oxygen saturation data and the input to the CO sensor shown at 42 is preferably the exhaled gas from the patient from which the end-tidal CO 2 concentration or the end-tidal partial pressure of CO 2 is determined by the sensor.
- the lung mechanics calculator and PV monitor, 34 receives data from the mechanical ventilator shown at 56, or from the patient through the ventilator circuit, on the line illustrated at 36 and communicates back to the ventilator as shown at 38.
- the digital processor's outputs shown at 44 are applied to a Signal Generator Circuit, illustrated at 46.
- the Signal Generator Circuit sends alarm instruction signals 52 to the alarm circuit 54.
- the mechanical ventilator 56 receives the control signals 48 from the Signal Generator Circuit 46. These consist of signals to control PEEP, breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient.
- a Mixer Regulator circuit 58 receives control signals to adjust F ⁇ , 50, from the Signal Generator Circuit 46.
- An oxygen air mixer 62 receives the adjusted output signal 60 from the Mixer Regulator 58. The concentration of oxygen in the mixer is thereby adjusted by mixing the determined concentration of oxygen 66 coming from the oxygen supply 70 and that of air 64 coming from the air compressor 68.
- the enriched oxygenated air 72 from the mixer is provided to the ventilator 56 which delivers it to the patient at 74.
- FIG. 2a-2c there is illustrated a flow chart of the algorithm to control the breathing frequency, ventilation, and the adjustment in the E ratio in an alternative embodiment of the invention.
- the initial values of breathing frequency and tidal volume are transmitted to the output ports in step 100.
- the main loop at A is started and in the next step at 102, based on data indicative of CO and O 2 levels of the patient which are preferably provided by a capnograph and a pulse oximeter respectively, the arterial partial pressures of CO and O 2 are calculated by using the following equations:
- P a co2 and P a o 2 are arterial partial pressures of CO 2 and O 2 respectively
- P et co 2 is the end-tidal partial pressure of CO 2 measured by the CO 2 sensor
- Ki is the difference between the arterial partial pressure of CO 2 and the end-tidal partial pressure of CO 2 .
- K] can be measured in advance and depending on the patient's conditions, it can be adjusted to set the desired P a co 2 of the patient.
- S p o 2 is the arterial hemoglobin oxygen saturation of the patient measured by a pulse oximeter and CP is an added correction factor which is used to correct and shift P a o 2 based on the patient's measured blood pH level.
- CP is set to zero. Otherwise, CP needs to be adjusted by +3.5 mm Hg per every -0.1 deviation in pH from the above range.
- P a co2 and P a o 2 their values are compared to defined minimum acceptable levels to determine whether there has been any measurement artifact in step 104. If any artifact is detected, the calculated value is discarded and the previous calculated value is resumed. In the next step at 106, if P a co 2 and/or P a o 2 are not within certain defined ranges, alarms are transmitted to the output ports.
- step 108 if the calculated P a co 2 and P a o 2 values are both lower than their minimum threshold limits (which are different from the minimum acceptable values used in step 104), the possibility of pulmonary embolism is assumed, predefined levels of ventilation and breathing frequency are provided, and an alarm is generated in steps 110 and 112, and the program returns to A. However, if the calculated P a co2 and P a o 2 values are not found to be simultaneously lower than their minimum threshold levels in 108, then the effect of CO 2 on the required ventilation is calculated in step 114:
- Vc is the ratio of alveolar ventilation as the net effect of CO 2 to the resting value of ventilation
- step 116 the P a o 2 value is compared to a high threshold limit of 104 mm Hg. If P a o 2 is greater than or equal to this threshold value, the effect of oxygen on ventilation is set to zero in 118, and the next step at 122 is followed. Otherwise, if P a o 2 is found to be less than the threshold value in step 116, then control is passed to step 120 in which the effect of oxygen on the required ventilation is calculated by using the following equation:
- Vo is the ratio of alveolar ventilation as the net effect of oxygen to the resting value of ventilation. It is recognized that the above equations are based on the use of a capnograph and a pulse oximeter to measure the carbon dioxide and oxygen levels of the patient respectively. If other measurement techniques are utilized to provide data indicative of said levels, then other alternative equations may be used to determine the required ventilation for the patient, without deviating from the scope and the essential attributes of the invention.
- V M 0.988(MRR - 1)
- V M is the ratio of alveolar ventilation as the net effect of increase in the metabolic rate ratio, MRR, to the resting value of ventilation, and MRR is an input to the algorithm.
- MRR is the ratio of alveolar ventilation as the net effect of increase in the metabolic rate ratio, MRR, to the resting value of ventilation
- MRR is an input to the algorithm.
- V A is alveolar ventilation in liters/minute and V A at rest is the alveolar ventilation at rest which is input and stored in the software .
- the physiological dead space of the patient, and the total dead space including that of the equipment are calculated, if not provided in advance, as follows:
- V D (0.1698V A /60) + 0.1587
- Vot V D + V ED
- V D is the patient's dead space in liters
- V ED is the equipment dead space due to the tubes and connections
- Vo t is the total dead space.
- the constant factors in these equations are based on measured experimental values for adults and can therefore be different for individual patients. Also, for other patient populations, they need to be adjusted. For example the constant factor of 0.1587 should change to a much smaller value for infants (e. g., 2.28x10 " ).
- data indicative of barometric pressure and the patient's airway resistance (or the air viscosity factor in the lungs) and respiratory elastance are read from the input ports.
- the barometric pressure data which is affected mostly by the altitude, is used as a reference pressure (for the purpose of calibration) in the invention.
- the optimal frequency for the next breath is computed. This calculation is based on minimization of the respiratory work rate and is done in order to stimulate natural breathing, provide a more comfortable breathing pattern to the patient, and thereby, expedite the weaning process in assisted ventilation.
- V A R is the alveolar ventilation in liters/second and is equal to V A /60
- K' is the respiratory elastance (reciprocal of respiratory compliance) in cm H 2 O/liter
- K" is the airway resistance in cm H 2 O/liter/second.
- V ⁇ V A /60f + V Dt [0029]
- V E represents total minute ventilation in liters/minute
- VT is tidal volume in liters.
- additional safety rules are applied. If breathing frequency, f, tidal volume, Vr, or minute ventilation are not within prescribed safe ranges, their values are limited and adjusted.
- the breathing frequency is compared with an upper limit value F max .
- T is the respiratory time constant and is equal to K'7 K'. If in step 136, the breathing frequency is found to be higher than F max , then in the next step at 138, its value is reduced to F ma ⁇ (in which case Vr is also adjusted according to procedures in steps 132 and 134), and step 140 is followed. Otherwise, if the computed breathing frequency is less than or equal to F max , it does not need further adjustment and the program is transferred to step 140. In step 140, the expiration time, T E , is compared to 2.5 times ⁇ .
- step 142 is followed and the I:E ratio (the ratio of the inspiratory time to the expiratory time) is adjusted, so that T E becomes at least equal to 2.5 T. Otherwise, if T E is found to be greater than or equal to 2.5 T in step 140, it does not need to be adjusted (i.e. the adjustment value is zero) and the program is transferred to step 144.
- the reason for the adjustments in the breathing frequency and T E in steps 138 and 142 mentioned above, is to provide sufficient time for exhalation based on the patient's respiratory time constant and to avoid build up of intrinsic positive end-expiratory pressure (PEEPi).
- PEEPi intrinsic positive end-expiratory pressure
- step 144 the calculated values for ventilation, breathing frequency, and the adjustment in the I:E ratio for the next breath are provided to the output ports.
- the inspiratory pressure is calculated by using the following equation:
- P m K'V ⁇ + PEEP where P m is the inspiratory pressure in cm H 2 O.
- the control data indicative of P m is also provided to an output port and the routine is held for the duration of the next breathing cycle. After the delay is passed, the program returns to the beginning of the loop at A.
- FIG. 3a-3i there is illustrated a flow chart of a control algorithm which is operated upon by the digital processor.
- This algorithm is either run by itself, or in an alternative embodiment of the invention, it is run in parallel to the algorithm of Figures 2a-2c described above.
- the purpose of this algorithm is to automatically control the levels of F102 and PEEP provided to the patient on the ventilator and thereby improve the patient's oxygenation.
- the method depicted in Figures 3a-3i can be used for patients on mechanical ventilation or those on respiratory assist devices receiving CPAP treatment.
- the term PEEP in the flow chart is meant to be interchangeable with CPAP.
- step 200 the desired set point for arterial partial pressure of oxygen of the patient is defined in step 200. This is done on the basis of the patient's conditions and his/her underlying illness. Then in the next step at 202, the initial value of F I02 is set and transmitted to the output port.
- the initial value of PEEP is set and transmitted to an output port.
- the initial value of PEEP can be set by using different options. For certain patient groups such as COPD patients, the initial PEEP can be chosen to be 80% to 85% of the intrinsic PEEP (PEEPi) which needs to be measured in advance. For some other patient groups such as ARDS patients, the initial PEEP setting can be chosen to be 3-4 cm H 2 O above the lower inflection pressure point of the inspiratory (or the expiratory) pressure volume curve of the patient. This value can either be calculated by the lung mechanics calculator and PV monitor unit and provided automatically to the digital processor via an input port, or the calculated value of the pressure can be provided manually by the clinician either through one of the input ports or via software.
- the third option is that the clinician arbitrarily decides an initial setting for PEEP and provides it to the digital processor, preferably via software.
- the next step in 206 is followed.
- a time parameter e.g., TP
- the purpose of defining this parameter is to guarantee that PEEP adjustments are done only after a certain time has elapsed since the latest adjustment, thereby giving enough time to an adjustment in PEEP to make an impact on the patient's oxygenation.
- step 208 which follows next, another parameter, AP, for PEEP adjustment is defined. If this parameter is set to zero, then PEEP is controlled manually and only F1 0 2 is automatically adjusted. If AP is set to one, then both F ⁇ )2 and PEEP are automatically controlled.
- the threshold values for arterial hemoglobin oxygen saturation, S p o 2 are defined. In a preferred practice of the invention, four threshold values are defined for S p o 2 and they are set at 90%, 93%, 95%, and 97% respectively. However, the threshold values may differ for different patients. They should be defined based on the patient's conditions and the desired levels of oxygenation.
- program control passes to step 212 in which a loop indicator (e.g., LI) is defined and is set to 1.5, and the main loop starts at A'.
- a loop indicator e.g., LI
- step 214 the patient's S p o2 data is read from one of the input ports, and in step 216, the arterial partial pressure of oxygen is calculated from the S- P0 2 data as:
- P a o 2 is the arterial partial pressure of oxygen
- CP is an added correction factor which is used to shift P a o 2 based on the patient's measured blood pH level. If the patient's blood pH is within 7.45-7.55, then CP is set to zero. Otherwise, for every +0.1 deviation in pH from this range, CP is adjusted by -3.5 mm Hg as was also mentioned in the description of Figure 2 earlier.
- step 218 the calculated partial pressure of oxygen, P- a o 2 , is compared with a minimum acceptable value. This is done to detect artifacts in the measurement of S p o 2 - If the calculated P a o 2 is found to be less than the minimum acceptable value, then control passes to step 220 in which an artifact is assumed and an alarm is generated. Then step 222 is performed in which the S p o2 data is discarded and the previous value of P a o 2 in the memory is resumed and step 224 is followed. However, if in 218, the calculated P a o 2 is found to be greater than or equal to the minimum acceptable value, its value is accepted and control passes to step 224.
- step 224 S p o 2 is compared to a minimum safe value, which is the first threshold value defined previously in step 210 (e.g., 90%). If S p o 2 is less than or equal to the minimum safe value, loop B is started in 226 and the loop indicator, LI, is set to 2.5. Then in step 228, F ⁇ o 2 is increased stepwise (i.e. in a step-like arrangement) to a high value, FI, (e.g., 60%), and an alarm is generated in 230. Control then passes to loop F at which the procedure of PEEP adjustment begins as will be described later.
- a minimum safe value which is the first threshold value defined previously in step 210 (e.g. 90%). If S p o 2 is less than or equal to the minimum safe value, loop B is started in 226 and the loop indicator, LI, is set to 2.5. Then in step 228, F ⁇ o 2 is increased stepwise (i.e. in a step-like arrangement) to a high value, FI, (e.g.
- a second threshold value e.g. 95%
- step 232 if S p02 is found to be higher than or equal to the 2 nd threshold value (e. g., 93%), then steps 242 and 244 are followed in which LI is compared to 2. If it is less than 2, control passes to loop E. Otherwise, in the next step at 246, LI is compared to 3. If less than 3, loop C is defined and started at 248, and LI is set to 3.5. Then in step 250, F 102 is set stepwise at a moderately high value, F2 (e.g., 45%), and control transfers to loop F in which the procedure of PEEP adjustment is followed. However, if in step 246, LI is found to be greater than or equal to 3, control passes to step 252 in which LI is compared to 4.
- the 2 nd threshold value e. g., 93%)
- S p o2 is compared to a third threshold value (e.g., 95%) in step 254. If S p o2 is less than the third threshold value, control passes to loop C in which F ⁇ ) 2 was set at a moderately high level, F2 (e.g., 45%). Otherwise, if S p o2 is found to be higher than or equal to the third threshold value in 254, then the next step in 256 is followed in which loop D is defined and started and LI is set to 4.5. Next in step 258, F 102 is set stepwise at a slightly high level, F3 (e.g., 30%), and control passes to loop F.
- a third threshold value e.g., 95%
- step 252 if LI is found to be greater than or equal to 4, then S p o 2 is compared to a 4 th threshold value (e.g., 97%) in step 260. If S p o2 is less than the 4 th threshold value, control passes to loop D in which F102 was set at a slightly high value, F3 (e.g., 30%). Otherwise, if S p o 2 is higher than or equal to the 4 th threshold value in 260, then loop E is started in 262 and LI is set to 1.5. In loop E, a proportional, integral, derivative (PID) control procedure is performed to adjust F10 2 (PID control is a control technique comprising proportional, integral, and derivative terms). In the next step at 264, using the P a o 2 set point defined in step 200, the proportional, differential, and integral components of error are calculated as follows:
- Y ⁇ (k), Y 2 (k), and Y 3 (k) represent the proportional, differential, and integral components of error in P a o 2 respectively, and T is a sampling interval.
- E(k) is an error function
- ⁇ , and ⁇ are the PID coefficients
- G(k) is the required F 102 -
- T is set to 0.75 seconds
- a, ⁇ , and ⁇ are set to 6.45xl0 "5 , 3.22xl0 "5 , and 7.29xl0 "6 respectively.
- step 270 the calculated value of F10 2 is compared with a minimum of 0.21 (i.e. 21%). If the F 102 value is less than 21%, in step 270 which follows, it is set to a minimum of 21% and control passes to loop F. However, if in 268, F 102 is found to be greater than or equal to 21%, control passes to step 272 in which F102 is compared to a maximum allowed value (e.g., 80%). If F ⁇ ) 2 is less than or equal to the maximum allowed value, the next step in 274 is followed where the calculated value of F K ⁇ is sent to the output port and control passes to step 276. In this step F > 2 is compared to 60%.
- a maximum allowed value e.g., 80%
- the controller switches from the PID control to the rapid stepwise algorithm only if rapid declines in S p o 2 are detected.
- the controller continuously checks S p o2, and if it rises, the controller reduces F 102 to minimize the exposure of the patient to high and toxic levels of F ⁇ o 2 -
- the controller is designed to correct hypoxemia within seconds and to avoid hyperoxemia. As shown, the controller detects artifacts in the measurement of S p o 2 , discards the artifacts, and generates alarms when appropriate.
- the algorithm also enables clinicians to define the desired oxygenation levels for different patients. This is done by defining an appropriate P a o2 set point, by setting the threshold values for S p o 2 , and by adjusting the correction parameter, CP, in accordance with the measured pH levels in the patient's blood as described above.
- the procedure of adjusting the PEEP value is started at F in step 282.
- the ratio of PEEP/F102 is calculated.
- the control parameter AP which was defined in step 208, is examined. If it is less than 1, it means that PEEP is not adjusted automatically and it is instead adjusted manually by the operator. In this case, the controller merely watches the PEEP/F1 02 ratio and generates warning signals, if the ratio is either too low or too high.
- the ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum value, an alarm is generated in 288 and control passes to I (which will be described later).
- step 286 if the PEEP/Frc ⁇ ratio is found to be equal to or greater than the minimum value in step 286, then the next step in 290 is performed where the ratio is compared to a maximum allowed value (e.g., 0.22). If the ratio is less than or equal to the maximum value, control passes to I. Otherwise, an alarm is generated in step 292 and then control is transferred to I.
- a maximum allowed value e.g. 0.25
- step 284 if AP is not less than 1, it means that PEEP should be calculated and automatically adjusted. Therefore, the automatic PEEP adjustment control loop is started next at G at step 294.
- the PEEP/F- !02 ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum, the procedure at H is started and it is examined how long ago the last adjustment in PEEP was made.
- the time parameter, TP is compared to a defined fixed interval, Tl, for example 240 seconds. If TP is less than 240 seconds, it means that the last PEEP adjustment was made less than 4 minutes ago. Then the procedure at J is started. Control passes to step 302 in which no change is made in PEEP and the time parameter, TP, is increased by a fixed amount (e.g., 0.75 seconds):
- a fixed amount e.g., 2 cm H 2 O
- step 308 if the PEEP/F I02 ratio is not found to be less than the minimum allowed value, control transfers to step 308.
- the routine is held for a fixed interval (e.g., 0.75 seconds) and then control returns to the beginning of the main loop at A'.
- step 320 is next followed.
- S p o 2 is compared to a predefined minimum allowed value (e.g., 92%). If it is higher than or at least equal to the predefined minimum value, the PEEP level is not changed and control passes to J. However, if in 320, S p o 2 is found to be less than the predefined minimum value, then control passes to H, where it is determined whether at least 4 minutes have passed since the last PEEP adjustment, and if so, PEEP is increased by a fixed amount (e. g., 2 cm H 2 O) as was shown earlier.
- a fixed amount e. g., 2 cm H 2 O
- the PEEP/F102 is kept within a clinically acceptable range. As shown above, if the PEEP/F1 0 2 is too low, PEEP is increased by a fixed increment (e.g., 2 cm H 2 O). Also, if the PEEP/F1 0 2 ratio is within the acceptable range and S p o 2 is low, then PEEP is increased by a fixed increment (e.g., 2 cm H 2 O) to improve patient's oxygenation. On the other hand, if the PEEP/F ⁇ o 2 ratio increases beyond a maximum defined value, the program reduces PEEP in fixed amounts (e.g., 2 cm H 2 O). In any case, the interval between two successive PEEP adjustments is at least equal to a fixed period (e.g., 240 seconds), to allow for the changes in PEEP to have an observable and measurable impact on the patient's oxygenation.
- a fixed period e.g., 240 seconds
- Figures 4a-c illustrate in detail, a preferred circuit diagram of the Signal Generator Circuit, 46, and the alarm circuit 54.
- the preferred component types and values are shown in the chart below:
- the invention utilizes data indicative of measured oxygen levels of the patient to automatically control F1 0 2, and PEEP (or CPAP).
- the invention further uses the respiratory mechanics data (i.e. respiratory elastance and airway resistance) to automatically make the necessary adjustments in the I:E ratio of the patient on the ventilator.
- It further incorporates the features of US Patent No. 4,986,268 and uses data indicative of measured levels of oxygen and the respiratory mechanics data of the patient, along with data indicative of barometric pressure (as a reference calibrating pressure), and data indicative of measured carbon dioxide level of the patient to automatically control the breathing frequency and tidal volume of breaths of the patient on the ventilator.
- the invention also detects and corrects artifacts in the measured oxygen and carbon dioxide data and applies safety rules.
- the invention can improve total and/or assist ventilatory treatments provided to different patient groups.
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2545570A CA2545570C (en) | 2003-11-21 | 2004-10-25 | Method and apparatus for controlling a ventilator |
NZ546941A NZ546941A (en) | 2003-11-21 | 2004-10-25 | Method and apparatus for controlling a ventilator |
AU2004292955A AU2004292955B2 (en) | 2003-11-21 | 2004-10-25 | Method and apparatus for controlling a ventilator |
GB0611065A GB2423721B (en) | 2003-11-21 | 2004-10-25 | Method and apparatus for controlling a ventilator |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48169303P | 2003-11-21 | 2003-11-21 | |
US60/481,693 | 2003-11-21 | ||
US10/935,446 US7802571B2 (en) | 2003-11-21 | 2004-09-07 | Method and apparatus for controlling a ventilator |
US10/935,446 | 2004-09-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005051280A2 true WO2005051280A2 (en) | 2005-06-09 |
WO2005051280A3 WO2005051280A3 (en) | 2006-05-26 |
Family
ID=34594521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/035393 WO2005051280A2 (en) | 2003-11-21 | 2004-10-25 | Method and apparatus for controlling a ventilator |
Country Status (6)
Country | Link |
---|---|
US (1) | US7802571B2 (en) |
AU (1) | AU2004292955B2 (en) |
CA (1) | CA2545570C (en) |
GB (1) | GB2423721B (en) |
NZ (1) | NZ546941A (en) |
WO (1) | WO2005051280A2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1930043A2 (en) | 2006-12-05 | 2008-06-11 | Weinmann Geräte für Medizin GmbH & Co. KG | Method and device for mixing oxygen into a breathing gas mixture |
GB2472116A (en) * | 2009-07-25 | 2011-01-26 | Fleur T Tehrani | A method and an apparatus for controlling a ventilator to automatically adjust ventilation assistance to an active or passive subject |
WO2012080903A1 (en) | 2010-12-17 | 2012-06-21 | Koninklijke Philips Electronics N.V. | System and method for customizable automated control of fraction of inspired oxygen and/or positive end expiratory pressure to maintain oxygenation |
US8528552B2 (en) | 2008-12-01 | 2013-09-10 | Dräger Medical GmbH | SPO2 control with adaptive linear compensation |
US8640700B2 (en) | 2008-03-27 | 2014-02-04 | Covidien Lp | Method for selecting target settings in a medical device |
US10514662B1 (en) | 2015-01-22 | 2019-12-24 | Vapotherm, Inc. | Oxygen mixing and delivery |
US11324954B2 (en) | 2019-06-28 | 2022-05-10 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
US11612706B2 (en) | 2019-11-25 | 2023-03-28 | John C. Taube | Methods, systems, and devices for controlling mechanical ventilation |
US11779720B2 (en) | 2019-11-04 | 2023-10-10 | Vapotherm, Inc. | Methods, devices, and systems for improved oxygenation patient monitoring, mixing, and delivery |
US12053588B2 (en) | 2014-12-31 | 2024-08-06 | Vapotherm, Inc. | Systems and methods for humidity control |
US12064562B2 (en) | 2020-03-12 | 2024-08-20 | Vapotherm, Inc. | Respiratory therapy unit with non-contact sensing and control |
Families Citing this family (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6782888B1 (en) * | 1999-04-07 | 2004-08-31 | Event Medical Ltd. | Breathing apparatus |
US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
WO2004075746A2 (en) | 2003-02-27 | 2004-09-10 | Cardiodigital Limited | Method and system for analysing and processing ph0t0plethysmogram signals using wavelet transform |
WO2005009291A2 (en) * | 2003-07-23 | 2005-02-03 | Synapse Biomedical, Inc. | System and method for conditioning a diaphragm of a patient |
US7415297B2 (en) * | 2004-03-08 | 2008-08-19 | Masimo Corporation | Physiological parameter system |
US20070044669A1 (en) * | 2005-08-24 | 2007-03-01 | Geise Gregory D | Aluminum can compacting mechanism with improved actuation handle assembly |
US9050005B2 (en) * | 2005-08-25 | 2015-06-09 | Synapse Biomedical, Inc. | Method and apparatus for transgastric neurostimulation |
US20070077200A1 (en) * | 2005-09-30 | 2007-04-05 | Baker Clark R | Method and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes |
JP2009519050A (en) * | 2005-12-02 | 2009-05-14 | シナプス・バイオメディカル・インコーポレイテッド | Trans visceral nerve stimulation mapping apparatus and method |
WO2007085110A1 (en) * | 2006-01-30 | 2007-08-02 | Hamilton Medical Ag | O2-controller |
US8676323B2 (en) * | 2006-03-09 | 2014-03-18 | Synapse Biomedical, Inc. | Ventilatory assist system and methods to improve respiratory function |
US7909033B2 (en) | 2006-05-03 | 2011-03-22 | Comedica Incorporated | Breathing treatment apparatus |
US8667963B2 (en) * | 2006-05-16 | 2014-03-11 | Impact Instrumentation, Inc. | Ventilator circuit for oxygen generating system |
US8051854B2 (en) * | 2006-09-15 | 2011-11-08 | Comedica Incorporated | Continuous high-frequency oscillation breathing treatment apparatus |
US20080066752A1 (en) * | 2006-09-20 | 2008-03-20 | Nellcor Puritan Bennett Inc. | Method and system for circulatory delay compensation in closed-loop control of a medical device |
US8728059B2 (en) * | 2006-09-29 | 2014-05-20 | Covidien Lp | System and method for assuring validity of monitoring parameter in combination with a therapeutic device |
EP2091429B1 (en) * | 2006-11-16 | 2010-11-10 | Hamilton Medical AG | Method and device for determining the peep during the respiration of a patient |
CA3000408C (en) | 2007-01-29 | 2024-04-02 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
US9079016B2 (en) * | 2007-02-05 | 2015-07-14 | Synapse Biomedical, Inc. | Removable intramuscular electrode |
US20080202521A1 (en) * | 2007-02-23 | 2008-08-28 | General Electric Company | Setting mandatory mechanical ventilation parameters based on patient physiology |
US20080202519A1 (en) * | 2007-02-23 | 2008-08-28 | General Electric Company | Setting mandatory mechanical ventilation parameters based on patient physiology |
US20080202518A1 (en) * | 2007-02-23 | 2008-08-28 | General Electric Company | Setting mandatory mechanical ventilation parameters based on patient physiology |
US20080202520A1 (en) | 2007-02-23 | 2008-08-28 | General Electric Company | Setting mandatory mechanical ventilation parameters based on patient physiology |
US20080202517A1 (en) * | 2007-02-23 | 2008-08-28 | General Electric Company | Setting madatory mechanical ventilation parameters based on patient physiology |
EP1961438A1 (en) * | 2007-02-23 | 2008-08-27 | The General Electric Company | Inhalation anaesthesia delivery system and method |
US20080230061A1 (en) * | 2007-03-23 | 2008-09-25 | General Electric Company | Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations |
US20080230064A1 (en) * | 2007-03-23 | 2008-09-25 | General Electric Company | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases |
US20080230063A1 (en) * | 2007-03-23 | 2008-09-25 | General Electric Company | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as forced inhalation time |
US20080230060A1 (en) * | 2007-03-23 | 2008-09-25 | General Electric Company | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired |
US8695593B2 (en) * | 2007-03-31 | 2014-04-15 | Fleur T. Tehrani | Weaning and decision support system for mechanical ventilation |
US8316849B2 (en) * | 2007-04-26 | 2012-11-27 | Buxco Electronics, Inc. | Integrated ventilator with calibration |
WO2008144578A1 (en) * | 2007-05-17 | 2008-11-27 | Synapse Biomedical, Inc. | Devices and methods for assessing motor point electromyogram as a biomarker |
US9050434B2 (en) * | 2007-05-18 | 2015-06-09 | Comedica Incorporated | Lung therapy device |
US8478412B2 (en) * | 2007-10-30 | 2013-07-02 | Synapse Biomedical, Inc. | Method of improving sleep disordered breathing |
US8428726B2 (en) | 2007-10-30 | 2013-04-23 | Synapse Biomedical, Inc. | Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system |
US9078984B2 (en) * | 2008-01-31 | 2015-07-14 | Massachusetts Institute Of Technology | Mechanical ventilator |
US8746248B2 (en) | 2008-03-31 | 2014-06-10 | Covidien Lp | Determination of patient circuit disconnect in leak-compensated ventilatory support |
US8272380B2 (en) | 2008-03-31 | 2012-09-25 | Nellcor Puritan Bennett, Llc | Leak-compensated pressure triggering in medical ventilators |
US8267085B2 (en) | 2009-03-20 | 2012-09-18 | Nellcor Puritan Bennett Llc | Leak-compensated proportional assist ventilation |
EP2313138B1 (en) | 2008-03-31 | 2018-09-12 | Covidien LP | System and method for determining ventilator leakage during stable periods within a breath |
US8425428B2 (en) | 2008-03-31 | 2013-04-23 | Covidien Lp | Nitric oxide measurements in patients using flowfeedback |
US8251876B2 (en) | 2008-04-22 | 2012-08-28 | Hill-Rom Services, Inc. | Breathing exercise apparatus |
WO2009137682A1 (en) | 2008-05-07 | 2009-11-12 | Lynn Lawrence A | Medical failure pattern search engine |
US8457706B2 (en) | 2008-05-16 | 2013-06-04 | Covidien Lp | Estimation of a physiological parameter using a neural network |
EP2320791B1 (en) | 2008-06-06 | 2016-08-31 | Covidien LP | Systems for ventilation in proportion to patient effort |
US8398555B2 (en) * | 2008-09-10 | 2013-03-19 | Covidien Lp | System and method for detecting ventilatory instability |
US8551006B2 (en) | 2008-09-17 | 2013-10-08 | Covidien Lp | Method for determining hemodynamic effects |
US8794234B2 (en) | 2008-09-25 | 2014-08-05 | Covidien Lp | Inversion-based feed-forward compensation of inspiratory trigger dynamics in medical ventilators |
US8652064B2 (en) * | 2008-09-30 | 2014-02-18 | Covidien Lp | Sampling circuit for measuring analytes |
US8302602B2 (en) | 2008-09-30 | 2012-11-06 | Nellcor Puritan Bennett Llc | Breathing assistance system with multiple pressure sensors |
US9155493B2 (en) | 2008-10-03 | 2015-10-13 | Nellcor Puritan Bennett Ireland | Methods and apparatus for calibrating respiratory effort from photoplethysmograph signals |
US9011347B2 (en) | 2008-10-03 | 2015-04-21 | Nellcor Puritan Bennett Ireland | Methods and apparatus for determining breathing effort characteristics measures |
US8428672B2 (en) * | 2009-01-29 | 2013-04-23 | Impact Instrumentation, Inc. | Medical ventilator with autonomous control of oxygenation |
US8424521B2 (en) | 2009-02-27 | 2013-04-23 | Covidien Lp | Leak-compensated respiratory mechanics estimation in medical ventilators |
US20100224191A1 (en) * | 2009-03-06 | 2010-09-09 | Cardinal Health 207, Inc. | Automated Oxygen Delivery System |
US10426906B2 (en) | 2009-03-18 | 2019-10-01 | Mayo Foundation For Medical Education And Research | Ventilator monitoring and control |
US8418691B2 (en) | 2009-03-20 | 2013-04-16 | Covidien Lp | Leak-compensated pressure regulated volume control ventilation |
US8408203B2 (en) * | 2009-04-30 | 2013-04-02 | General Electric Company | System and methods for ventilating a patient |
US8550077B2 (en) * | 2009-05-19 | 2013-10-08 | The Cleveland Clinic Foundation | Ventilator control system utilizing a mid-frequency ventilation pattern |
US8444570B2 (en) * | 2009-06-09 | 2013-05-21 | Nellcor Puritan Bennett Ireland | Signal processing techniques for aiding the interpretation of respiration signals |
US20100331716A1 (en) * | 2009-06-26 | 2010-12-30 | Nellcor Puritan Bennett Ireland | Methods and apparatus for measuring respiratory function using an effort signal |
US20100331715A1 (en) * | 2009-06-30 | 2010-12-30 | Nellcor Puritan Bennett Ireland | Systems and methods for detecting effort events |
US8755854B2 (en) | 2009-07-31 | 2014-06-17 | Nellcor Puritan Bennett Ireland | Methods and apparatus for producing and using lightly filtered photoplethysmograph signals |
US8789529B2 (en) | 2009-08-20 | 2014-07-29 | Covidien Lp | Method for ventilation |
US8596270B2 (en) * | 2009-08-20 | 2013-12-03 | Covidien Lp | Systems and methods for controlling a ventilator |
US20110100360A1 (en) * | 2009-11-02 | 2011-05-05 | Joseph Dee Faram | Composite lung therapy device and method |
US9151425B2 (en) * | 2009-11-02 | 2015-10-06 | Comedica Incorporated | Multiple conduit connector apparatus and method |
US8638200B2 (en) | 2010-05-07 | 2014-01-28 | Covidien Lp | Ventilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient |
JP2013533760A (en) * | 2010-06-10 | 2013-08-29 | オリディオン メディカル 1987 リミテッド | Weaning from artificial respiration using capnography |
US8607790B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component |
US8607788B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component |
US8607791B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation |
US8607789B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component |
US8676285B2 (en) | 2010-07-28 | 2014-03-18 | Covidien Lp | Methods for validating patient identity |
US8834378B2 (en) | 2010-07-30 | 2014-09-16 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiratory effort |
US8554298B2 (en) | 2010-09-21 | 2013-10-08 | Cividien LP | Medical ventilator with integrated oximeter data |
JP6320755B2 (en) * | 2010-11-23 | 2018-05-09 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Obesity hypoventilation syndrome treatment system and method |
US8595639B2 (en) | 2010-11-29 | 2013-11-26 | Covidien Lp | Ventilator-initiated prompt regarding detection of fluctuations in resistance |
US8757153B2 (en) | 2010-11-29 | 2014-06-24 | Covidien Lp | Ventilator-initiated prompt regarding detection of double triggering during ventilation |
US8757152B2 (en) | 2010-11-29 | 2014-06-24 | Covidien Lp | Ventilator-initiated prompt regarding detection of double triggering during a volume-control breath type |
US9038633B2 (en) | 2011-03-02 | 2015-05-26 | Covidien Lp | Ventilator-initiated prompt regarding high delivered tidal volume |
US8714154B2 (en) | 2011-03-30 | 2014-05-06 | Covidien Lp | Systems and methods for automatic adjustment of ventilator settings |
US8776792B2 (en) | 2011-04-29 | 2014-07-15 | Covidien Lp | Methods and systems for volume-targeted minimum pressure-control ventilation |
US8801619B2 (en) | 2011-06-30 | 2014-08-12 | Covidien Lp | Photoplethysmography for determining ventilation weaning readiness |
US9089657B2 (en) | 2011-10-31 | 2015-07-28 | Covidien Lp | Methods and systems for gating user initiated increases in oxygen concentration during ventilation |
US9364624B2 (en) | 2011-12-07 | 2016-06-14 | Covidien Lp | Methods and systems for adaptive base flow |
US9498589B2 (en) | 2011-12-31 | 2016-11-22 | Covidien Lp | Methods and systems for adaptive base flow and leak compensation |
US9022031B2 (en) | 2012-01-31 | 2015-05-05 | Covidien Lp | Using estimated carinal pressure for feedback control of carinal pressure during ventilation |
CN107126622A (en) | 2012-03-05 | 2017-09-05 | 西蒙·弗雷瑟大学 | neural stimulation system |
US9180271B2 (en) | 2012-03-05 | 2015-11-10 | Hill-Rom Services Pte. Ltd. | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
US9024756B2 (en) * | 2012-03-28 | 2015-05-05 | J And N Enterprises Inc. | Immediate detection system and method thereof |
US8844526B2 (en) | 2012-03-30 | 2014-09-30 | Covidien Lp | Methods and systems for triggering with unknown base flow |
EP2830498A1 (en) * | 2012-03-30 | 2015-02-04 | Koninklijke Philips N.V. | System and method for power of breathing real-time assessment and closed-loop controller |
US9131881B2 (en) * | 2012-04-17 | 2015-09-15 | Masimo Corporation | Hypersaturation index |
US9993604B2 (en) | 2012-04-27 | 2018-06-12 | Covidien Lp | Methods and systems for an optimized proportional assist ventilation |
JP6359528B2 (en) | 2012-06-21 | 2018-07-18 | ラングペーサー メディカル インコーポレイテッドLungpacer Medical Inc. | Transvascular diaphragm pacing system and method of use |
US10362967B2 (en) | 2012-07-09 | 2019-07-30 | Covidien Lp | Systems and methods for missed breath detection and indication |
US9027552B2 (en) | 2012-07-31 | 2015-05-12 | Covidien Lp | Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation |
EP2895223B1 (en) | 2012-09-12 | 2019-05-22 | Maquet Critical Care AB | An anesthesia system, a method and a computer-readable medium for actively controlling oxygen delivered to a patient |
US9375542B2 (en) | 2012-11-08 | 2016-06-28 | Covidien Lp | Systems and methods for monitoring, managing, and/or preventing fatigue during ventilation |
US10354429B2 (en) | 2012-11-14 | 2019-07-16 | Lawrence A. Lynn | Patient storm tracker and visualization processor |
US9953453B2 (en) | 2012-11-14 | 2018-04-24 | Lawrence A. Lynn | System for converting biologic particle density data into dynamic images |
US12080401B2 (en) | 2012-12-03 | 2024-09-03 | Metrohealth Ventures Llc | Combination respiratory therapy device, system and method |
US9795752B2 (en) | 2012-12-03 | 2017-10-24 | Mhs Care-Innovation, Llc | Combination respiratory therapy device, system, and method |
US9492629B2 (en) | 2013-02-14 | 2016-11-15 | Covidien Lp | Methods and systems for ventilation with unknown exhalation flow and exhalation pressure |
WO2014134512A1 (en) | 2013-02-28 | 2014-09-04 | Lynn Lawrence A | System and method for biologic particle density path projection |
US9358355B2 (en) | 2013-03-11 | 2016-06-07 | Covidien Lp | Methods and systems for managing a patient move |
US9981096B2 (en) | 2013-03-13 | 2018-05-29 | Covidien Lp | Methods and systems for triggering with unknown inspiratory flow |
US10449311B2 (en) | 2013-06-05 | 2019-10-22 | Thornhill Scientific Inc. | Controlling arterial blood gas concentration |
WO2014194401A1 (en) * | 2013-06-05 | 2014-12-11 | Michael Klein | Controlling arterial blood gas concentration |
US9675771B2 (en) | 2013-10-18 | 2017-06-13 | Covidien Lp | Methods and systems for leak estimation |
US10022068B2 (en) | 2013-10-28 | 2018-07-17 | Covidien Lp | Systems and methods for detecting held breath events |
WO2015075548A1 (en) | 2013-11-22 | 2015-05-28 | Simon Fraser University | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
CA2935454A1 (en) | 2014-01-21 | 2015-07-30 | Simon Fraser University | Systems and related methods for optimization of multi-electrode nerve pacing |
WO2015136405A1 (en) * | 2014-03-11 | 2015-09-17 | Koninklijke Philips N.V. | Reducing hypercapnic respiratory failure during mechanical ventilation |
US9839760B2 (en) * | 2014-04-11 | 2017-12-12 | Vyaire Medical Capital Llc | Methods for controlling mechanical lung ventilation |
US10183139B2 (en) | 2014-04-11 | 2019-01-22 | Vyaire Medical Capital Llc | Methods for controlling mechanical lung ventilation |
US9956365B2 (en) | 2014-04-11 | 2018-05-01 | Vyaire Medical Capital Llc | Lung ventilation apparatus |
US9808591B2 (en) | 2014-08-15 | 2017-11-07 | Covidien Lp | Methods and systems for breath delivery synchronization |
US20160058346A1 (en) * | 2014-09-02 | 2016-03-03 | General Electric Company | Determination of arterial co2 partial pressure |
US9950129B2 (en) | 2014-10-27 | 2018-04-24 | Covidien Lp | Ventilation triggering using change-point detection |
CN107427259B (en) * | 2014-12-31 | 2021-03-16 | 皇家飞利浦有限公司 | System for performing histogram analysis of time-based capnography signals and method of operation thereof |
US9925346B2 (en) | 2015-01-20 | 2018-03-27 | Covidien Lp | Systems and methods for ventilation with unknown exhalation flow |
DE102015103894A1 (en) * | 2015-03-17 | 2016-09-22 | Fritz Stephan Gmbh Medizintechnik | Respirators and control methods for ventilators |
CN104834326B (en) * | 2015-04-01 | 2017-12-19 | 深圳市科曼医疗设备有限公司 | Lung ventilator oxygen concentration control method, device and system |
WO2016159889A1 (en) | 2015-04-02 | 2016-10-06 | Hill-Rom Services Pte. Ltd. | Manifold for respiratory device |
WO2016210382A1 (en) * | 2015-06-24 | 2016-12-29 | Chris Salvino | Oxygen biofeedback device and methods |
WO2017079798A1 (en) * | 2015-11-10 | 2017-05-18 | University Of Tasmania | Method, apparatus and system for automatically controlling inspired oxygen delivery |
US11154215B2 (en) * | 2016-12-05 | 2021-10-26 | Medipines Corporation | System and methods for respiratory measurements using breathing gas samples |
US10357624B2 (en) * | 2016-12-06 | 2019-07-23 | Iasset Ag | Ventilator apparatus and method for operating a ventilator in said ventilator apparatus |
US11351320B2 (en) | 2017-02-22 | 2022-06-07 | Koninklijke Philips N.V. | Automatic PEEP selection for mechanical ventilation |
US10293164B2 (en) | 2017-05-26 | 2019-05-21 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
WO2019006239A1 (en) | 2017-06-30 | 2019-01-03 | Lungpacer Medical Inc. | Devices for prevention, moderation, and/or treatment of cognitive injury |
US10195429B1 (en) | 2017-08-02 | 2019-02-05 | Lungpacer Medical Inc. | Systems and methods for intravascular catheter positioning and/or nerve stimulation |
US10940308B2 (en) | 2017-08-04 | 2021-03-09 | Lungpacer Medical Inc. | Systems and methods for trans-esophageal sympathetic ganglion recruitment |
CN117563098A (en) | 2017-10-06 | 2024-02-20 | 斐雪派克医疗保健有限公司 | Breathing apparatus |
AU2018353928B2 (en) | 2017-11-14 | 2019-06-13 | Covidien Lp | Methods and systems for drive pressure spontaneous ventilation |
US20190175908A1 (en) | 2017-12-11 | 2019-06-13 | Lungpacer Medical Inc. | Systems and methods for strengthening a respiratory muscle |
US11478594B2 (en) | 2018-05-14 | 2022-10-25 | Covidien Lp | Systems and methods for respiratory effort detection utilizing signal distortion |
CN108904938B (en) * | 2018-07-20 | 2024-03-22 | 张锦洪 | Simple respirator device with function of accurately measuring tidal volume |
US11517691B2 (en) | 2018-09-07 | 2022-12-06 | Covidien Lp | Methods and systems for high pressure controlled ventilation |
US11933453B2 (en) * | 2018-09-25 | 2024-03-19 | 3M Innovative Properties Company | Dynamically determining safety equipment for dynamically changing environments |
US11752287B2 (en) | 2018-10-03 | 2023-09-12 | Covidien Lp | Systems and methods for automatic cycling or cycling detection |
EP3877043A4 (en) | 2018-11-08 | 2022-08-24 | Lungpacer Medical Inc. | Stimulation systems and related user interfaces |
WO2020103163A1 (en) * | 2018-11-23 | 2020-05-28 | 深圳迈瑞生物医疗电子股份有限公司 | Positive end expiratory pressure determining method and apparatus, aeration device, and storage medium |
CN111888599B (en) * | 2018-12-10 | 2022-10-04 | 深圳市科曼医疗设备有限公司 | Pressure maintaining device of breathing machine |
US11471683B2 (en) | 2019-01-29 | 2022-10-18 | Synapse Biomedical, Inc. | Systems and methods for treating sleep apnea using neuromodulation |
US20220133223A1 (en) * | 2019-02-15 | 2022-05-05 | Children's Medical Center Corporation | Summarial scores for an emr platform |
CN111694382B (en) * | 2019-03-15 | 2024-06-25 | 欧姆龙健康医疗(中国)有限公司 | Gas supply concentration adjusting method, gas supply concentration adjusting system and oxygenerator |
JP2022532375A (en) | 2019-05-16 | 2022-07-14 | ラングペーサー メディカル インコーポレイテッド | Systems and methods for detection and stimulation |
WO2020252037A1 (en) | 2019-06-12 | 2020-12-17 | Lungpacer Medical Inc. | Circuitry for medical stimulation systems |
WO2021026621A1 (en) * | 2019-08-12 | 2021-02-18 | Britto Azevedo Schneider Felipe | Pressure and flow generator for mechanical veterinary pulmonary ventilation |
US12070554B2 (en) | 2019-11-11 | 2024-08-27 | Hill-Rom Services Pte. Ltd. | Pneumatic connector apparatus and method |
US11813399B2 (en) | 2019-11-28 | 2023-11-14 | Liauna Kelly | Continuous positive airway pressure (CPAP) apparatus and system |
DE102021000313A1 (en) * | 2020-02-06 | 2021-08-12 | Löwenstein Medical Technology S.A. | Method for operating a ventilator for artificial ventilation of a patient and such a ventilator |
CN112316264B (en) * | 2020-11-24 | 2024-09-17 | 方梁 | Wall breathing oxygen automatic device for hospital |
EP4313226A1 (en) * | 2021-03-30 | 2024-02-07 | Zoll Medical Corporation | Closed loop control in mechanical ventilation |
WO2023122903A1 (en) * | 2021-12-27 | 2023-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | Ventilation control method and device |
DE102022117141A1 (en) | 2022-07-08 | 2024-01-11 | Löwenstein Medical Technology Sa | Ventilator and method for supplying breathing gas |
CN115887841B (en) * | 2022-08-19 | 2024-08-20 | 湖南万脉医疗科技有限公司 | Breathing machine flow control method based on sleep state and sleep breathing machine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4986268A (en) * | 1988-04-06 | 1991-01-22 | Tehrani Fleur T | Method and apparatus for controlling an artificial respirator |
US5558086A (en) * | 1992-12-16 | 1996-09-24 | Freedom Air Services | Method and apparatus for the intermittent delivery of oxygen therapy to a person |
US6116241A (en) * | 1996-07-08 | 2000-09-12 | Siemens-Elema Ab | Method and apparatus for determining when a partially or completely collapsed lung has been opened |
US6158432A (en) * | 1995-12-08 | 2000-12-12 | Cardiopulmonary Corporation | Ventilator control system and method |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2414747A (en) | 1942-07-02 | 1947-01-21 | Harry M Kirschbaum | Method and apparatus for controlling the oxygen content of the blood of living animals |
GB835192A (en) | 1958-08-06 | 1960-05-18 | Philip Lockland Stanton | Pressure breathing therapy apparatus |
US3734091A (en) | 1971-06-22 | 1973-05-22 | Airco Inc | Oxygen control system with blood oxygen saturation sensing means and method for closed system breathing |
US4121578A (en) | 1976-10-04 | 1978-10-24 | The Bendix Corporation | Physiological responsive control for an oxygen regulator |
DE2926747C2 (en) | 1979-07-03 | 1982-05-19 | Drägerwerk AG, 2400 Lübeck | Ventilation system with a ventilator controlled by patient values |
US4448192A (en) | 1982-03-05 | 1984-05-15 | Hewlett Packard Company | Medical ventilator device parametrically controlled for patient ventilation |
FR2530148B1 (en) | 1982-07-13 | 1985-11-29 | France Prod Oxygenes Co | DEVICE FOR THE TREATMENT OF PATIENT RESPIRATORY FAILURE |
US4665911A (en) | 1983-11-25 | 1987-05-19 | Electro-Fluidics | Intermittent supplemental oxygen apparatus and method |
US4584996A (en) | 1984-03-12 | 1986-04-29 | Blum Alvin S | Apparatus for conservative supplemental oxygen therapy |
US4773411A (en) | 1986-05-08 | 1988-09-27 | Downs John B | Method and apparatus for ventilatory therapy |
GB8719333D0 (en) | 1987-08-14 | 1987-09-23 | Swansea University College Of | Motion artefact rejection system |
US4889116A (en) | 1987-11-17 | 1989-12-26 | Phospho Energetics, Inc. | Adaptive control of neonatal fractional inspired oxygen |
US5103814A (en) | 1988-04-28 | 1992-04-14 | Timothy Maher | Self-compensating patient respirator |
US5532958A (en) * | 1990-06-25 | 1996-07-02 | Dallas Semiconductor Corp. | Dual storage cell memory |
US5632269A (en) | 1989-09-22 | 1997-05-27 | Respironics Inc. | Breathing gas delivery method and apparatus |
DE69131836T2 (en) | 1990-09-19 | 2000-07-27 | The University Of Melbourne, Parkville | CONTROL CIRCUIT FOR MONITORING THE ARTERIAL CO 2 CONTENT |
US5365922A (en) * | 1991-03-19 | 1994-11-22 | Brigham And Women's Hospital, Inc. | Closed-loop non-invasive oxygen saturation control system |
US5315990A (en) | 1991-12-30 | 1994-05-31 | Mondry Adolph J | Method for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels |
US5682877A (en) | 1991-12-30 | 1997-11-04 | Mondry; Adolph J. | System and method for automatically maintaining a blood oxygen saturation level |
US5388575A (en) * | 1992-09-25 | 1995-02-14 | Taube; John C. | Adaptive controller for automatic ventilators |
DE4309923C2 (en) | 1993-03-26 | 1995-02-16 | Boesch Wilhelm | Device for supplying breathing gas to a patient |
DE69305178T2 (en) | 1993-12-11 | 1997-02-13 | Hewlett Packard Gmbh | Method for detecting an abnormal condition in a pulse powered oximeter system |
SE9400487L (en) | 1994-02-14 | 1995-03-13 | Siemens Elema Ab | A ventilator / respirator |
US6105575A (en) | 1994-06-03 | 2000-08-22 | Respironics, Inc. | Method and apparatus for providing positive airway pressure to a patient |
FI954092A (en) | 1994-09-08 | 1996-03-09 | Weinmann G Geraete Med | Method of controlling a respirator in the treatment of sleep apnea |
SE9502032D0 (en) | 1995-06-02 | 1995-06-02 | Burkhard Lachmann | Arrangement for determining an opening pressure |
SE9502543D0 (en) | 1995-07-10 | 1995-07-10 | Lachmann Burkhardt | Artificial ventilation system |
US6463930B2 (en) | 1995-12-08 | 2002-10-15 | James W. Biondi | System for automatically weaning a patient from a ventilator, and method thereof |
US6148814A (en) | 1996-02-08 | 2000-11-21 | Ihc Health Services, Inc | Method and system for patient monitoring and respiratory assistance control through mechanical ventilation by the use of deterministic protocols |
US5692497A (en) | 1996-05-16 | 1997-12-02 | Children's Medical Center Corporation | Microprocessor-controlled ventilator system and methods |
US5705735A (en) * | 1996-08-09 | 1998-01-06 | Medical Graphics Corporation | Breath by breath nutritional requirements analyzing system |
US6355022B1 (en) * | 1998-05-01 | 2002-03-12 | The Procter & Gamble Company | Absorbent interlabial device with substance thereon for maintaining the device in position |
AU8592898A (en) | 1997-07-25 | 1999-02-16 | Minnesota Innovative Technologies & Instruments Corporation (Miti) | Control device for supplying supplemental respiratory oxygen |
US6532958B1 (en) | 1997-07-25 | 2003-03-18 | Minnesota Innovative Technologies & Instruments Corporation | Automated control and conservation of supplemental respiratory oxygen |
US6371114B1 (en) | 1998-07-24 | 2002-04-16 | Minnesota Innovative Technologies & Instruments Corporation | Control device for supplying supplemental respiratory oxygen |
US6655382B1 (en) | 1997-09-18 | 2003-12-02 | The United States Of America As Represented By The Secretary Of Health And Human Services | Spontaneous breathing apparatus and method |
US5937854A (en) | 1998-01-06 | 1999-08-17 | Sensormedics Corporation | Ventilator pressure optimization method and apparatus |
SE9801175D0 (en) | 1998-04-03 | 1998-04-03 | Innotek Ab | Method and apparatus for optimizing mechanical ventilation based on simulation of the ventilation process after studying the physiology of the respiratory organs |
AUPP366398A0 (en) | 1998-05-22 | 1998-06-18 | Resmed Limited | Ventilatory assistance for treatment of cardiac failure and cheyne-stokes breathing |
US6390940B1 (en) * | 1998-12-01 | 2002-05-21 | William Naulls | Basketball game, apparatus and method of play |
EP1148907B1 (en) | 1999-01-29 | 2003-12-10 | Siemens-Elema AB | Non-invasive method for optimizing the respiration of atelectatic lungs |
US6390091B1 (en) | 1999-02-03 | 2002-05-21 | University Of Florida | Method and apparatus for controlling a medical ventilator |
DE60020842T2 (en) * | 1999-06-30 | 2006-05-18 | University of Florida Research Foundation, Inc., Gainesville | MONITORING SYSTEM FOR VENTILATOR |
US20070000494A1 (en) | 1999-06-30 | 2007-01-04 | Banner Michael J | Ventilator monitor system and method of using same |
US6355002B1 (en) | 2000-05-22 | 2002-03-12 | Comedica Technologies Incorporated | Lung inflection point monitor apparatus and method |
US6752151B2 (en) | 2000-09-25 | 2004-06-22 | Respironics, Inc. | Method and apparatus for providing variable positive airway pressure |
US6512938B2 (en) | 2000-12-12 | 2003-01-28 | Nelson R. Claure | System and method for closed loop controlled inspired oxygen concentration |
US7246618B2 (en) | 2001-06-21 | 2007-07-24 | Nader Maher Habashi | Ventilation method and control of a ventilator based on same |
US6575918B2 (en) | 2001-09-27 | 2003-06-10 | Charlotte-Mecklenburg Hospital | Non-invasive device and method for the diagnosis of pulmonary vascular occlusions |
ES2592262T3 (en) * | 2003-08-04 | 2016-11-29 | Carefusion 203, Inc. | Portable respirator system |
-
2004
- 2004-09-07 US US10/935,446 patent/US7802571B2/en active Active
- 2004-10-25 GB GB0611065A patent/GB2423721B/en not_active Expired - Lifetime
- 2004-10-25 AU AU2004292955A patent/AU2004292955B2/en not_active Expired
- 2004-10-25 CA CA2545570A patent/CA2545570C/en not_active Expired - Lifetime
- 2004-10-25 WO PCT/US2004/035393 patent/WO2005051280A2/en active Application Filing
- 2004-10-25 NZ NZ546941A patent/NZ546941A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4986268A (en) * | 1988-04-06 | 1991-01-22 | Tehrani Fleur T | Method and apparatus for controlling an artificial respirator |
US5558086A (en) * | 1992-12-16 | 1996-09-24 | Freedom Air Services | Method and apparatus for the intermittent delivery of oxygen therapy to a person |
US6158432A (en) * | 1995-12-08 | 2000-12-12 | Cardiopulmonary Corporation | Ventilator control system and method |
US6116241A (en) * | 1996-07-08 | 2000-09-12 | Siemens-Elema Ab | Method and apparatus for determining when a partially or completely collapsed lung has been opened |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1930043A2 (en) | 2006-12-05 | 2008-06-11 | Weinmann Geräte für Medizin GmbH & Co. KG | Method and device for mixing oxygen into a breathing gas mixture |
US8640700B2 (en) | 2008-03-27 | 2014-02-04 | Covidien Lp | Method for selecting target settings in a medical device |
US8640699B2 (en) | 2008-03-27 | 2014-02-04 | Covidien Lp | Breathing assistance systems with lung recruitment maneuvers |
US8528552B2 (en) | 2008-12-01 | 2013-09-10 | Dräger Medical GmbH | SPO2 control with adaptive linear compensation |
GB2472116A (en) * | 2009-07-25 | 2011-01-26 | Fleur T Tehrani | A method and an apparatus for controlling a ventilator to automatically adjust ventilation assistance to an active or passive subject |
GB2472116B (en) * | 2009-07-25 | 2015-05-27 | Fleur T Tehrani | Automatic control system for mechanical ventilation for active or passive subjects |
WO2012080903A1 (en) | 2010-12-17 | 2012-06-21 | Koninklijke Philips Electronics N.V. | System and method for customizable automated control of fraction of inspired oxygen and/or positive end expiratory pressure to maintain oxygenation |
US9937308B2 (en) | 2010-12-17 | 2018-04-10 | Koninklijke Philips N.V. | System and method for customizable automated control of fraction of inspired oxygen and/or positive end expiratory pressure to maintain oxygenation |
US12053588B2 (en) | 2014-12-31 | 2024-08-06 | Vapotherm, Inc. | Systems and methods for humidity control |
US10514662B1 (en) | 2015-01-22 | 2019-12-24 | Vapotherm, Inc. | Oxygen mixing and delivery |
US11853084B1 (en) | 2015-01-22 | 2023-12-26 | Vapotherm, Inc. | Oxygen mixing and delivery |
US11092984B1 (en) | 2015-01-22 | 2021-08-17 | Vapotherm, Inc. | Oxygen mixing and delivery |
US11324954B2 (en) | 2019-06-28 | 2022-05-10 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
US12036409B2 (en) | 2019-06-28 | 2024-07-16 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
US11779720B2 (en) | 2019-11-04 | 2023-10-10 | Vapotherm, Inc. | Methods, devices, and systems for improved oxygenation patient monitoring, mixing, and delivery |
US11612706B2 (en) | 2019-11-25 | 2023-03-28 | John C. Taube | Methods, systems, and devices for controlling mechanical ventilation |
US12064562B2 (en) | 2020-03-12 | 2024-08-20 | Vapotherm, Inc. | Respiratory therapy unit with non-contact sensing and control |
Also Published As
Publication number | Publication date |
---|---|
GB2423721B (en) | 2008-11-12 |
GB2423721A (en) | 2006-09-06 |
AU2004292955B2 (en) | 2010-02-18 |
NZ546941A (en) | 2009-01-31 |
WO2005051280A3 (en) | 2006-05-26 |
CA2545570C (en) | 2012-01-03 |
CA2545570A1 (en) | 2005-06-09 |
GB0611065D0 (en) | 2006-07-12 |
AU2004292955A1 (en) | 2005-06-09 |
US7802571B2 (en) | 2010-09-28 |
US20050109340A1 (en) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7802571B2 (en) | Method and apparatus for controlling a ventilator | |
US9604021B2 (en) | Automatic control system for mechanical ventilation for active or passive subjects | |
JP5016595B2 (en) | Apparatus and method for controlling inspiratory oxygen concentration | |
JP2023153858A (en) | Methods and apparatus for oxygenation and/or co2 clearance | |
US9884159B2 (en) | Method and system for controlling breathing | |
US8408203B2 (en) | System and methods for ventilating a patient | |
AU757163B2 (en) | Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep | |
US20080202522A1 (en) | Setting mandatory mechanical ventilation parameters based on patient physiology | |
US20080230062A1 (en) | Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of exhaled gas volumes | |
WO1992011052A1 (en) | Anesthesia emergence system using closed-loop pco¿2? | |
US20080230061A1 (en) | Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations | |
US20080230064A1 (en) | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases | |
US20080230060A1 (en) | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired | |
EP1961378A1 (en) | Setting mandatory mechanical ventilation parameters based on patient physiology | |
US20230157574A1 (en) | End tidal carbon dioxide measurement during high flow oxygen therapy | |
Tehrani et al. | Closed-loop control of artificial respiration | |
WO2015002662A1 (en) | Method and system for controlling breathing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004292955 Country of ref document: AU Ref document number: 546941 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2545570 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
ENP | Entry into the national phase |
Ref document number: 2004292955 Country of ref document: AU Date of ref document: 20041025 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004292955 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 0611065.4 Country of ref document: GB Ref document number: 0611065 Country of ref document: GB |
|
122 | Ep: pct application non-entry in european phase |